Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack

Duane H. Hamilton(National Cancer Institute), Claudia Palena(National Cancer Institute)
Frontiers in Oncology
May 3, 2018
Cited by 11


Related Papers